Alexo-Tech AB is a research-focused organization located in Umeå, specializing in amyloid research. The company is dedicated to advancing scientific understanding of amyloids, which are proteins that can aggregate and form fibrils associated with various diseases. Their research encompasses several key areas, including transthyretin (TTR) studies, alpha-synuclein (Alpha-syn) investigations, and the exploration of apolipoprotein E (ApoE). Additionally, Alexo-Tech conducts studies on IAPP/Amylin and amyloid-beta, contributing to the broader field of amyloid-related research.
In support of their research initiatives, Alexo-Tech AB offers a range of proteins and peptides, as well as a catalog of antibodies. This includes specific antibodies for transthyretin (TTR) and alpha-synuclein, which are critical tools for researchers studying these proteins and their roles in disease. By providing these resources, Alexo-Tech aims to facilitate further research and understanding of amyloid-related conditions, thereby contributing to the scientific community's efforts in this area.